InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: dia76ca post# 12279

Monday, 12/20/2021 2:30:21 PM

Monday, December 20, 2021 2:30:21 PM

Post# of 14947
I know they have to see the safety and efficacy of second generation oncolytic virus Seprehvec in monotherapy...but I look forward to seeing it combined with a second generation systemic anti-CTLA4! This could be amazing! And I wonder how it might work with Abivertinib...a true wonder drug!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News